Tandem Diabetes Care TNDM Standard and Extended Product Warranty Accrual
Standard and Extended Product Warranty Accrual at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:ProductWarrantyAccrual.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's standard and extended product warranty accrual.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's standard and extended product warranty accrual?
- Tandem Diabetes Care (TNDM) reported standard and extended product warranty accrual of $55.11M in Q1 2026.
- How has Tandem Diabetes Care's standard and extended product warranty accrual changed year-over-year?
- Tandem Diabetes Care's standard and extended product warranty accrual increased by 5.6% year-over-year, from $52.21M to $55.11M.
- What is the long-term trend for Tandem Diabetes Care's standard and extended product warranty accrual?
- Over 5 years (2020 to 2025), Tandem Diabetes Care's standard and extended product warranty accrual has grown at a 20.2% compound annual growth rate (CAGR), from $22.08M to $55.32M.